Pharmacy Times Continuing Education™ (PTCE)’s Post

Did you know that only about 36% of patients diagnosed with lung cancer receive the right treatment? Access the AMCP Market Insights report, Bridging the Gaps in Precision Oncology: Opportunities in Non-Small Cell Lung Cancer, to discover how effective referral, utilization management, and advanced diagnostics can improve patient outcomes and reduce costs. Visit the AMCP Market Insights resource page to learn more: https://bit.ly/4efCk4W #managedcare #pharmacy #oncology

Gain a better understanding of how to improve precision oncology in non-small cell lung cancer (NSCLC) with AMCP's Market Insights Best Practice infographic. View six best practices including how to use education and standardization to improve comprehensive biomarker testing in NSCLC. Visit the AMCP Market Insights resource page to download the infographic: https://bit.ly/4efCk4W #managedcare #pharmacy #oncology #nsclc

Advance your Breast Cancer drug development program with a very rare TNBC PDX model, CTG-3884. This model is BRCA1 mutant and derived from a patient pretreated and refractory to niraparib, a PARP inhibitor. Learn more about this model in Lumin (https://hubs.li/Q02FHqwK0) or contact us https://hubs.li/Q02FHBwG0. #breastcancer #drugdevelopment #TNBC #PDXmodel #BRCA1 #niraparib #PARP #PARPinhibitor #Lumin #oncologyresearch #oncology

Exploring the Potential of ONX-1006: A Detailed Assessment of the Calculation and Demonstration of a Safe, Non-Toxic Dose for Our Pancreatic Cancer Drug Candidate. The exceptional safety profile of ONX-1006. #pancreaticcancer #CancerTreatment #CancerResearch #Oncology

Top Companies with CAR-T Drugs in the Pipeline Curious about which companies are leading the charge in CAR-T drugs? See who's making waves in oncology and stay ahead of the latest developments with LARVOL PULSE. 🧬 Stay informed as breakthroughs happen. Learn more 👉 bit.ly/4canQRC #LARVOL #LARVOLPulse #Oncology #CART #CancerResearch #CancerCare #CancerTherapies #PrecisionMedicine #OncologyUpdates

Can human poop save the lives of cancer patients? Reading about the early-stage trials of MaaT Pharma fecal-based cancer treatments is inspirational. #CancerResearch #FecalTransplant #MedicalInnovation #HealthCare #Oncology #ClinicalTrials #MaaTPharma #Biotech

LARVOL is looking forward to Pharma CI Conference USA in Newark, NJ, from September 25-26, 2024! ✨ Our team will also be presenting on “Using AI to Predict Trial Completion and Outcome in Oncology Trials.” We look forward to sharing insights on the impact of AI in oncology research. Don’t miss it! 🤩 #PharmaCI #AIinOncology #Oncology #CancerResearch #CancerData #AI #AIinMedicine #LARVOL

Discover how personalised dosing can lead to improved outcomes in cancer care. Join experts in #oncology and #pharmacy to address key challenges and solutions. Don't miss Era of Personalized Medicine: What's Next? Personalised Dosing in Novel and Targeted Cancer Therapeutics, May 25 at 10:00 AM HKT. Register now: https://lnkd.in/et-TjGuZ

Understanding ONX-1006: A Detailed Assessment of the Calculation and Demonstration of a Safe, Non-Toxic Dose for Our Pancreatic Cancer Drug Candidate. The exceptional safety profile of ONX-1006. #pancreaticcancer #CancerTreatment #CancerResearch #Oncology

Watch our webinar with Amplia Therapeutics Limited, featuring CEO and MD Chris Burns. The webinar will commence with a presentation, followed by a live Q&A with the audience, providing you the opportunity to ask Chris any questions about ATX that you may have. Key topics: - Data from recent trial - Why ovarian and pancreatic cancer? - What are the next key milestones and value drivers? - Where were the drugs discovered? Register here: https://hubs.la/Q02zctXZ0